{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:49:24Z","timestamp":1792601364072,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-04296-7","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T13:51:58Z","timestamp":1749649918000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Nicotinamide for secondary keratinocyte carcinoma prevention in solid organ transplant recipients"],"prefix":"10.1007","volume":"317","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6415-9369","authenticated-orcid":false,"given":"Jonathan C.","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1541-5060","authenticated-orcid":false,"given":"Kevin T.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2127-1929","authenticated-orcid":false,"given":"Melissa","family":"Pugliano-Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"key":"4296_CR1","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3390\/nu16010100","volume":"16","author":"G Tosti","year":"2023","unstructured":"Tosti G, Pepe F, Gnagnarella P et al (2023) The role of nicotinamide as chemo-preventive agent in NMSCs: A systematic review and meta-analysis. Nutrients 16:100. https:\/\/doi.org\/10.3390\/nu16010100","journal-title":"Nutrients"},{"key":"4296_CR2","doi-asserted-by":"publisher","unstructured":"Snaidr VA, Damian DL, Halliday GM (2019) Nicotinamide for photoprotection and skin cancer chemoprevention: a review of efficacy and safety. Exp Dermatol 28 Suppl 115\u201322. https:\/\/doi.org\/10.1111\/exd.13819","DOI":"10.1111\/exd.13819"},{"key":"4296_CR3","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41591-023-02793-8","volume":"30","author":"M Ferrell","year":"2024","unstructured":"Ferrell M, Wang Z, Anderson JT et al (2024) A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk. Nat Med 30:424\u2013434. https:\/\/doi.org\/10.1038\/s41591-023-02793-8","journal-title":"Nat Med"},{"key":"4296_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/carcin\/bgn248","volume":"30","author":"E Yiasemides","year":"2008","unstructured":"Yiasemides E, Sivapirabu G, Halliday GM et al (2008) Oral nicotinamide protects against ultraviolet radiation-induced immunosuppression in humans. Carcinogenesis 30:101\u2013105. https:\/\/doi.org\/10.1093\/carcin\/bgn248","journal-title":"Carcinogenesis"},{"key":"4296_CR5","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1039\/b9pp00146h","volume":"9","author":"DL Damian","year":"2010","unstructured":"Damian DL (2010) Photoprotective effects of nicotinamide. Photochem Photobiol Sci 9:578\u2013585. https:\/\/doi.org\/10.1039\/b9pp00146h","journal-title":"Photochem Photobiol Sci"},{"key":"4296_CR6","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/j.1365-2133.2009.09244.x","volume":"161","author":"G Sivapirabu","year":"2009","unstructured":"Sivapirabu G, Yiasemides E, Halliday G et al (2009) Topical nicotinamide modulates cellular energy metabolism and provides broad-spectrum protection against ultraviolet radiation-induced immunosuppression in humans. Br J Dermatol 161:1357\u20131364. https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09244.x","journal-title":"Br J Dermatol"},{"key":"4296_CR7","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1038\/jid.2011.459","volume":"132","author":"D Surjana","year":"2012","unstructured":"Surjana D, Halliday GM, Martin AJ et al (2012) Oral nicotinamide reduces actinic keratoses in phase II double-blinded randomized controlled trials. J Invest Dermatol 132:1497\u20131500. https:\/\/doi.org\/10.1038\/jid.2011.459","journal-title":"J Invest Dermatol"},{"key":"4296_CR8","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1056\/NEJMoa1506197","volume":"373","author":"AC Chen","year":"2015","unstructured":"Chen AC, Martin AJ, Choy B et al (2015) A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. N Engl J Med 373:1618\u20131626. https:\/\/doi.org\/10.1056\/NEJMoa1506197","journal-title":"N Engl J Med"},{"key":"4296_CR9","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1056\/NEJMoa2203086","volume":"388","author":"NC Allen","year":"2023","unstructured":"Allen NC, Martin AJ, Snaidr VA et al (2023) Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients. N Engl J Med 388:804\u2013812. https:\/\/doi.org\/10.1056\/NEJMoa2203086","journal-title":"N Engl J Med"},{"key":"4296_CR10","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1056\/NEJMc2303841","volume":"388","author":"CD Schmults","year":"2023","unstructured":"Schmults CD, Jambusaria-Pahlajani A, Ruiz E (2023) Comment on: Nicotinamide for skin-cancer chemoprevention in transplant recipients by Allen. N Engl J Med 388:2493\u20132495. https:\/\/doi.org\/10.1056\/NEJMc2303841","journal-title":"N Engl J Med"},{"key":"4296_CR11","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.jaad.2022.11.044","volume":"88","author":"MA Kreher","year":"2023","unstructured":"Kreher MA, Noland MMB, Konda S et al (2023) Risk of melanoma and nonmelanoma skin cancer with immunosuppressants, part I: Calcineurin inhibitors, thiopurines, IMDH inhibitors, mTOR inhibitors, and corticosteroids. J Am Acad Dermatol 88:521\u2013530. https:\/\/doi.org\/10.1016\/j.jaad.2022.11.044","journal-title":"J Am Acad Dermatol"},{"key":"4296_CR12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12874-021-01440-5","volume":"21","author":"E Bosco","year":"2021","unstructured":"Bosco E, Hsueh L, McConeghy KW et al (2021) Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review. BMC Med Res Methodol 21:241. https:\/\/doi.org\/10.1186\/s12874-021-01440-5","journal-title":"BMC Med Res Methodol"},{"key":"4296_CR13","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.jaad.2023.11.034","volume":"90","author":"S Bhullar","year":"2024","unstructured":"Bhullar S, Christensen SR (2024) Effectiveness of acitretin for skin cancer prevention in immunosuppressed and nonimmunosuppressed patients: A retrospective cohort study. J Am Acad Dermatol 90:821\u2013822. https:\/\/doi.org\/10.1016\/j.jaad.2023.11.034","journal-title":"J Am Acad Dermatol"},{"key":"4296_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2188\/jea.JE20160166","volume":"28","author":"I Savoye","year":"2018","unstructured":"Savoye I, Olsen CM, Whiteman DC et al (2018) Patterns of ultraviolet radiation exposure and skin cancer risk: the E3N-SunExp study. J Epidemiol 28:27\u201333. https:\/\/doi.org\/10.2188\/jea.JE20160166","journal-title":"J Epidemiol"},{"key":"4296_CR15","doi-asserted-by":"publisher","first-page":"102379","DOI":"10.1016\/j.canep.2023.102379","volume":"85","author":"SG Lashway","year":"2023","unstructured":"Lashway SG, Worthen ADM, Abuasbeh JN et al (2023) A meta-analysis of sunburn and basal cell carcinoma risk. Cancer Epidemiol 85:102379. https:\/\/doi.org\/10.1016\/j.canep.2023.102379","journal-title":"Cancer Epidemiol"},{"key":"4296_CR16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/exd.12430","volume":"23","author":"BC Thompson","year":"2014","unstructured":"Thompson BC, Surjana D, Halliday GM, Damian DL (2014) Nicotinamide enhances repair of ultraviolet radiation-induced DNA damage in primary melanocytes. Exp Dermatol 23:509\u2013511. https:\/\/doi.org\/10.1111\/exd.12430","journal-title":"Exp Dermatol"},{"key":"4296_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/exd.12388","volume":"23","author":"C Battie","year":"2014","unstructured":"Battie C, Jitsukawa S, Bernerd F et al (2014) New insights in photoaging, UVA induced damage and skin types. Exp Dermatol 23:7\u201312. https:\/\/doi.org\/10.1111\/exd.12388","journal-title":"Exp Dermatol"},{"key":"4296_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/jdv.14092","volume":"31","author":"E Stockfleth","year":"2017","unstructured":"Stockfleth E (2017) The importance of treating the field in actinic keratosis. J Eur Acad Dermatol Venereol 31:8\u201311. https:\/\/doi.org\/10.1111\/jdv.14092","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4296_CR19","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1056\/NEJMc2303841","volume":"388","author":"N Trepanowski","year":"2023","unstructured":"Trepanowski N, Kim DY, Hartman RI, Allen et al (2023) N Engl J Med 388:2493\u20132495. https:\/\/doi.org\/10.1056\/NEJMc2303841","journal-title":"N Engl J Med"},{"key":"4296_CR20","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/bjd.15324","volume":"177","author":"AC Green","year":"2017","unstructured":"Green AC, Olsen CM (2017) Cutaneous squamous cell carcinoma: an epidemiological review. Br J Dermatol 177:373\u2013381. https:\/\/doi.org\/10.1111\/bjd.15324","journal-title":"Br J Dermatol"},{"key":"4296_CR21","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/ajt.13596","volume":"16","author":"AE Coghill","year":"2016","unstructured":"Coghill AE, Johnson LG, Berg D et al (2016) Immunosuppressive medications and squamous cell skin carcinoma: nested case-control study within the skin cancer after organ transplant (SCOT) cohort. Am J Transpl Off J Am Soc Transpl Am Soc Transpl Surg 16:565\u2013573. https:\/\/doi.org\/10.1111\/ajt.13596","journal-title":"Am J Transpl Off J Am Soc Transpl Am Soc Transpl Surg"},{"key":"4296_CR22","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41598-023-50602-6","volume":"14","author":"W Lim","year":"2024","unstructured":"Lim W, Moon S, Lee NR et al (2024) Group I pharmaceuticals of IARC and associated cancer risks: systematic review and meta-analysis. Sci Rep 14:413. https:\/\/doi.org\/10.1038\/s41598-023-50602-6","journal-title":"Sci Rep"},{"key":"4296_CR23","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1365-2133.2008.08610.x","volume":"159","author":"CM Perrett","year":"2008","unstructured":"Perrett CM, Walker SL, O\u2019Donovan P et al (2008) Azathioprine treatment photosensitizes human skin to ultraviolet A radiation. Br J Dermatol 159:198\u2013204. https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08610.x","journal-title":"Br J Dermatol"},{"key":"4296_CR24","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1126\/science.1114233","volume":"309","author":"P O\u2019Donovan","year":"2005","unstructured":"O\u2019Donovan P, Perrett CM, Zhang X et al (2005) Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 309:1871\u20131874. https:\/\/doi.org\/10.1126\/science.1114233","journal-title":"Science"},{"key":"4296_CR25","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1111\/ajt.13863","volume":"16","author":"Z Jiyad","year":"2016","unstructured":"Jiyad Z, Olsen CM, Burke MT et al (2016) Azathioprine and Risk of Skin Cancer in Organ Transplant Recipients: Systematic Review and Meta-Analysis. Am J Transpl Off J Am Soc Transpl Am Soc Transpl Surg 16:3490\u20133503. https:\/\/doi.org\/10.1111\/ajt.13863","journal-title":"Am J Transpl Off J Am Soc Transpl Am Soc Transpl Surg"},{"key":"4296_CR26","unstructured":"(2025) Nicotinamide. In: Walmart.com. https:\/\/www.walmart.com\/c\/kp\/nicotinamide"},{"key":"4296_CR27","unstructured":"(2025) Amazon. Amazon. (2025). https:\/\/www.amazon.com\/s?k=nicotinamide+500mg+bid%26;crid=1J0XJ3Z6CR5PF%26;sprefix=nicotinamide+500mg+bid%2Caps%2C84%26;ref=nb_sb_noss"},{"key":"4296_CR28","first-page":"13","volume":"8","author":"P Starr","year":"2015","unstructured":"Starr P (2015) Oral Nicotinamide Prevents Common Skin Cancers in High-Risk Patients, Reduces Costs. Am Health Drug Benefits 8:13\u201314","journal-title":"Am Health Drug Benefits"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04296-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-04296-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04296-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T13:51:59Z","timestamp":1749649919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-04296-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4296"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-04296-7","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"807"}}